Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 500 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, carmellosum natricum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 1 mg, ad granulatum, pro charta 930 mg corresp. natrium 1.62 mg. - la colite ulcéreuse - synthetika

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 1 g, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, carmellosum natricum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 2 mg, ad granulatum, pro charta 1.86 g corresp. natrium 3.24 mg. - la colite ulcéreuse - synthetika

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 1.5 g, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 3 mg, ad granulatum, pro charta 2.79 g corresp. natrium 4.86 mg. - la colite ulcéreuse - synthetika

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 3000 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum, e 171, aromatica (vanille-creme), aspartamum 6 mg, ad granulatum, pro charta 5.58 g corresp. natrium 9.72 mg. - la colite ulcéreuse - synthetika

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - budesonidum - rektalschaum - budesonidum 2 mg, propylenglycolum 600.3 mg, alcohol cetylicus et stearylicus 12.6-15.12 mg, polysorbatum 60, macrogoli 10 aether stearylicus, alcohol cetylicus 8.4 mg, acidum citricum monohydricum, dinatrii edetas, aqua purificata ad emulsionem pro dosi, propellentia: butanum, isobutanum, propanum. - la colite ulcéreuse - synthetika

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - rektalschaum - mesalazinum 1000 mg, polysorbatum 60, alcohol cetylicus et stearylicus 9.1 mg, dinatrii edetas, propylenglycolum 3436 mg, e 223, nitrogenium, propanum et butanum et isobutanum, propellentia et ad suspensionem pro dosi. - la colite ulcéreuse - synthetika

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - budesonidum - magensaftresistentes granulat - budesonidum 9 mg, sacchari sphaerae corresp. saccharum 828 mg, lactosum monohydricum 36 mg, povidonum k 25, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum b, ammonio methacrylatis copolymerum a, triethylis citras, talcum, aromatica zitrone cum citralum et citronellolum et limonenum et geraniolum et linaloolum, xanthani gummi, sorbitolum 899.5 mg, acidum citricum, sucralosum, magnesii stearas, ad granulatum pro charta. - morbus crohn, kollagene colitis - synthetika

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - mesalazinum - 1,2 g de comprimés à libération prolongée comprimé gastro-résistant - mesalazinum 1.2 g, carmellosum natricum, cera carnauba, acidum stearicum, silica colloidalis hydrica, carboxymethylamylum natricum a, talcum, magnesii stearas, Überzug: talcum, acidi methacrylici copolymerum a, acidi methacrylici copolymerum b, triethylis citras, macrogolum 6000, e 171, e 172 (rubrum) pro compresso obducto corresp. natrium 5.66 mg. - la colite ulcéreuse - synthetika

Sviss - franska - Swissmedic (Swiss Agency for Therapeutic Products)

ferring ag - budesonidum - retardtabletten - budesonidum 9 mg, acidum stearicum, lecithinum ex soja, cellulosum microcristallinum, hydroxypropylcellulosum, lactosum monohydricum corresp. lactosum 47.5 mg, silica colloidalis hydrica, magnesii stearas, Überzug: acidi methacrylici copolymerum a, acidi methacrylici copolymerum b, talcum, triethylis citras, e 171 pro compresso obducto. - légère à modérément sévère de la colite ulcéreuse - synthetika

Kanada - franska - Health Canada

sanofi-aventis canada inc - cromolyne sodique - capsule - 100mg - cromolyne sodique 100mg - mast-cell stabilizers